Melfalax 50mg Injection
Marketer
GLS Pharma Ltd.
Salt Composition
Melphalan (50mg)
Overview Melfalax 50mg Injection
Oncaspar 50mg injection, a chemotherapy agent, treats ovarian cancer and multiple myeloma (a bone marrow cancer). Other uses are determined by a physician. Administered intravenously by a healthcare professional only, the dosage and frequency are individualized based on your condition and may vary. Therapeutic effects might not be immediately apparent; discontinue use only under medical supervision. Photosensitivity is a side effect; sun protection is vital. Common side effects include nausea, vomiting, anemia, and alopecia. Reduced blood cell counts increase infection risk. Regular blood tests monitor blood cell counts and kidney, liver, and heart function. Report any infections (fever, chills, aches), unusual bleeding (bruising, gum bleeding, hematuria, melena), or other concerning symptoms. Prior to treatment, disclose any bleeding disorders, liver or kidney issues, or current medications, especially anti-infectives. Drug interactions are possible; inform your doctor of all medications. Avoid pregnancy; effective contraception is crucial for both partners during treatment and for a period thereafter.
Primary Ingredients of Melfalax 50mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Melfalax 50mg Injection
Myeloma and ovarian cancer
Major Benefits of Melfalax 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strongly discouraged.
Common Side effects of Melfalax 50mg Injection:
- Hair loss
- Low blood platelets
- Diarrhea
- Decreased white blood cell count
- Nausea
- Vomiting
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
How to use Melfalax 50mg Injection:
Administering this medication will be handled by your physician or registered nurse; please refrain from self-medicating.
How Melfalax 50mg Injection works:
Oncolyx 50mg injection, an antineoplastic agent, disrupts the genetic structure (DNA and RNA) of malignant cells, thus inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCAUTION
Using Melfalax 50mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Melfalax 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Melfalax 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingCONSULT YOUR DOCTOR
Melfalax 50mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Melfalax 50mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Melfalax 50mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Melfalax 50mg Injection :
Should you inadvertently skip a dose of your 50mg Melfalax injection, seek immediate medical advice. Regular dosing is crucial.
Facts to Know About Melfalax 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Alkylating Agents (Nitrogen Mustard Class) |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently